← Back to the brief
istitlaa (ISTITL) · Public Consultation

Saudi Food and Drug Authority: Regulatory Guidance for the Integration of New Approach Methodologies (NAMs) and Artificial Intelligence (AI) in Preclinical Submissions

الهيئة العامة للغذاء والدواء: دليل استخدام الطرق الحديثة والذكاء الاصطناعي في الدراسات ما قبل السريرية

Action required (deferred)Reference

This guidance aims to establish a standardized approach to integrating NAMs and AI into preclinical drug development, fostering innovation while ensuring adherence to safety standards.

PublishedNovember 5, 2026
Consultation closesDecember 4, 2026
GazetteNot gazetted
Original source ↗

Saudi regulatory updates, in one morning brief

Bawadir tracks what Saudi regulators issue and delivers what needs your attention each working morning. Your email is all we ask for.

Check out the checklists →

Free. One click to unsubscribe, any time.